Loading clinical trials...
Loading clinical trials...
This protocol proposes to establish gene expression profiles of muscular dystrophies for correct diagnosis and for development of experimental therapies for these diseases.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Wake Forest University Health Sciences
NCT06817382 · Duchenne Muscular Dystrophy
NCT06839469 · Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy (DMD)
NCT06907875 · Facioscapulohumeral Muscular Dystrophy
NCT07037862 · Duchenne Muscular Dystrophy (DMD)
NCT01568658 · Muscular Dystrophies, Muscle Myopathies, and more
Carolinas Medical Center - Dept of Neurology
Charlotte, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions